WE ENVISION A WORLD IN WHICH NO ONE DIES FROM ALS

Target ALS: Collaborating to Accelerate Progress

Daniel L. Doctoroff, Founder and Board Chair

After losing both his father and uncle to ALS, former New York City Deputy Mayor and CEO of Sidewalk Labs, Dan Doctoroff knew something had to be done against this terrible disease. In 2013, he launched Target ALS to create a new collaborative framework for scientists and clinicians across academia and industry.

The Target ALS Innovation Ecosystem, a radically different approach to driving ALS research, brings together the right people, funding, critical tools and resources to accelerate the discovery and development of breakthrough therapies to treat people with ALS.

Learn more about how our Innovation Ecosystem works.

Our Impact

100+ Research Collaborators

50+ Pharma and Biotech Partners

12+ Therapeutic Approaches

See the impact of our Innovation Ecosystem.

Learn More